Treatment of TIGAR-overexpressing ESCC cell xenografts and patient-derived tumor xenografts in mice with a combination of glutaminase inhibitor and chemotherapeutic agents achieves significantly more efficacy than chemotherapy alone [30]. This evidence concerns the gene GLS and neoplasm.